Profile of extended-release oxycodone/acetaminophen for acute pain

Area of Science:

• Pharmacology
• Pain Management
• Drug Development

Background:

• Current opioid analgesics for acute pain often have short durations of action.
• Existing combination analgesics, like Percocet (oxycodone/acetaminophen), are typically immediate-release (IR) formulations.
• There is a need for formulations providing both rapid and sustained pain relief.

Purpose of the Study:

• To provide a historical and pharmacological overview of a novel extended-release (ER) oxycodone/acetaminophen formulation.
• To highlight the benefits of this new ER formulation for acute pain management.
• To compare the ER formulation with existing immediate-release (IR) opioid analgesics.

Main Methods:

• Historical review of opioid analgesic development.
• Pharmacological analysis of ER oxycodone/acetaminophen.
• Comparison with current FDA-approved IR formulations.

Main Results:

• The new ER oxycodone/acetaminophen formulation is designed for up to 12 hours of analgesia.
• It offers concurrent immediate and prolonged pain relief.
• Provides multimodal analgesia by combining an opioid (oxycodone) with a nonopioid (acetaminophen).

Conclusions:

• The ER oxycodone/acetaminophen represents a significant advancement in acute pain management.
• This novel formulation offers advantages over existing IR combination analgesics.
• It addresses the need for sustained and effective pain relief with a dual-action mechanism.